Form 8-K - Current report:
SEC Accession No. 0001193125-25-137162
Filing Date
2025-06-06
Accepted
2025-06-06 17:00:55
Documents
12
Period of Report
2025-06-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d48764d8k.htm   iXBRL 8-K 32087
  Complete submission text file 0001193125-25-137162.txt   142138

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rlay-20250606.xsd EX-101.SCH 2838
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rlay-20250606_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rlay-20250606_pre.xml EX-101.PRE 10804
14 EXTRACTED XBRL INSTANCE DOCUMENT d48764d8k_htm.xml XML 3496
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39385 | Film No.: 251031890
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)